Grade My Investments
HomeFree Stock Grades › LNDC

Landec Corporation (LNDC) Stock Grade

LNDC · Healthcare

B
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$301.0M
P/E Ratio
57.0
Revenue Growth (YoY)
+0.5%
Net Margin
-30.0%
Return on Equity
Dividend Yield
0.8%

About Landec Corporation's fundamentals

Landec Corporation, with a market capitalization of $301.0 million, is currently unprofitable with a net margin of -30.0% and reported a net loss in its latest annual statement. The company's revenue grew only 0.5% year-over-year, indicating minimal top-line expansion despite operating in the specialty and generic drug manufacturing sector. Trading at a P/E ratio of 57.0, the valuation reflects investor positioning ahead of potential profitability; however, the company's current negative earnings and stagnant revenue growth present significant operational challenges. The company offers a modest dividend yield of 0.8% to shareholders.

Track LNDC free — no credit card required. Live grade + monthly AI report →